Cargando…

Enhanced Remdesivir Analogues to Target SARS-CoV-2

We report the short synthesis of novel C-nucleoside Remdesivir analogues, their cytotoxicity and an in vitro evaluation against SARS-CoV-2 (CoV2). The described compounds are nucleoside analogues bearing a nitrogen heterocycle as purine analogues. The hybrid structures described herein are designed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majima, Ryuichi, Edwards, Tiffany C., Dreis, Christine D., Geraghty, Robert J., Bonnac, Laurent F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052049/ https://www.ncbi.nlm.nih.gov/pubmed/36985586 http://dx.doi.org/10.3390/molecules28062616

Ejemplares similares

Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
por: Geraghty, Robert J., et al.
Publicado: (2021)

Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies
por: Soto-Acosta, Ruben, et al.
Publicado: (2021)

Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase
por: Jung, Eunkyung, et al.
Publicado: (2022)

Design of novel pyrimidine based remdesivir analogues with dual target specificity for SARS CoV-2: A computational approach
por: Dinesh, T.V., et al.
Publicado: (2023)

Probing remdesivir nucleotide analogue insertion to SARS-CoV-2 RNA dependent RNA polymerase in viral replication
por: Romero, Moises E., et al.
Publicado: (2022)

Early experience with remdesivir in SARS-CoV-2 pneumonia
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2020)

Contre Sars-CoV-2, brequinar ou remdesivir ?
por: Manus, Jean-Marie
Publicado: (2021)

Remdesivir therapy associated with Bradycardia in SARS‐CoV2
por: Kumar, Sabina, et al.
Publicado: (2021)

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
por: Kokic, Goran, et al.
Publicado: (2021)

Remdesivir–ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2
por: Jeffreys, Laura N., et al.
Publicado: (2022)

Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection
por: Vulturar, Damiana-Maria, et al.
Publicado: (2022)

Arguments in favour of remdesivir for treating SARS-CoV-2 infections
por: Ko, Wen-Chien, et al.
Publicado: (2020)

Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia()
por: Cacho, Judit, et al.
Publicado: (2022)

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
por: Pruijssers, Andrea J., et al.
Publicado: (2020)

Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Dobrovolny, Hana M.
Publicado: (2020)

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Williamson, Brandi N., et al.
Publicado: (2020)

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Williamson, Brandi N., et al.
Publicado: (2020)

Remdesivir, la esperanza antiviral frente al SARS-CoV-2
por: Reina, Jordi
Publicado: (2020)

Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir
por: Lo, Ho Sing, et al.
Publicado: (2021)

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
por: Yoon, Jin Gu, et al.
Publicado: (2022)

Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication
por: Bravo, Jack P.K., et al.
Publicado: (2021)

The strand-biased transcription of SARS-CoV-2 and unbalanced inhibition by remdesivir
por: Zhao, Yan, et al.
Publicado: (2021)

Liver and Renal Injury with Remdesivir Treatment in SARS-CoV-2 Patients
por: Sadaf, Rabiah, et al.
Publicado: (2023)

Nucleotide analogues as inhibitors of SARS‐CoV Polymerase
por: Ju, Jingyue, et al.
Publicado: (2020)

Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues
por: Daikopoulou, Vasiliki, et al.
Publicado: (2021)

Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2
por: Nayeem, Shaik Mahammad, et al.
Publicado: (2021)

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
por: Choy, Ka-Tim, et al.
Publicado: (2020)

Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir
por: Chen, Ting, et al.
Publicado: (2021)

Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex
por: Wu, Jiqin, et al.
Publicado: (2021)

Hybrid physiologically‐based pharmacokinetic model for remdesivir: Application to SARS‐CoV‐2
por: Gallo, James M.
Publicado: (2021)

In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2
por: Szemiel, Agnieszka M., et al.
Publicado: (2021)

Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir
por: Negru, Paul Andrei, et al.
Publicado: (2022)

Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic
por: Poliseno, Mariacristina, et al.
Publicado: (2021)

487. Experience with Remdesivir for Treatment of SARS-CoV-2 in Patients with Liver Cirrhosis
por: Saunders-Hao, Patricia, et al.
Publicado: (2021)

Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir
por: Moreno, Santiago, et al.
Publicado: (2022)

Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection
por: Cacho, Judit, et al.
Publicado: (2022)

Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection
por: Heyer, Andreas, et al.
Publicado: (2022)

The kinetics of SARS-CoV-2 viremia in COVID-19 patients receiving remdesivir
por: Krifors, Anders, et al.
Publicado: (2023)

Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2022)

Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
por: Lo, Michael K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6dneiq0ikpdlhuaolblrnsqjcl